{"id":"W2038780142","doi":"10.1016/j.ejca.2015.02.005","title":"Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer","year":2015,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"GlaxoSmithKline","keywords":"Medicine; Minimal clinically important difference; Quality of life (healthcare); Lapatinib; Placebo; Breast cancer; Discontinuation; SF-36; Randomized controlled trial; Internal medicine; Physical therapy; Adverse effect; Cancer; Health related quality of life; Disease; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01585239,0.0002607349,0.002923366,0.000520531,0.00002568544,0.00001475789,0.000332954,0.00007749933,0.0006465787],"category_scores_gemma":[0.003489321,0.0002044241,0.0002993407,0.0004347202,0.0002378472,0.0001985066,0.00007254731,0.0009934782,0.000001185939],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001644889,"about_ca_system_score_gemma":0.00412212,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00998591,"about_ca_topic_score_gemma":0.0004711682,"domain_scores_codex":[0.9877687,0.005707784,0.004126907,0.0002715703,0.001462805,0.0006622377],"domain_scores_gemma":[0.9938034,0.0005223629,0.003686737,0.0003088144,0.0009247441,0.0007539847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8076482,0.0008505424,0.1434945,0.0008131264,0.0005018591,0.0000667301,0.02151365,0.0002831592,0.01639161,0.00001332962,0.0009370564,0.007486199],"study_design_scores_gemma":[0.6716018,0.002602907,0.3206353,0.002476115,0.00003393076,0.000006030274,0.001090692,0.00003956471,0.001063233,0.000009932566,0.0002653564,0.0001751433],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936742,0.002172035,0.00001005143,0.001166592,0.0003245349,0.001558936,0.0001818156,0.00001090408,0.0009009281],"genre_scores_gemma":[0.9986515,0.0004401248,0.00009931056,0.00009163441,0.0003358253,0.00003744605,0.000002747937,0.00008276202,0.0002586366],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1771408,"threshold_uncertainty_score":0.9966067,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09232333326504484,"score_gpt":0.4008121555903717,"score_spread":0.3084888223253269,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}